Glen Clova Scientific

Glen Clova Scientific is a biotechnology company developing active biologic drugs for chronic inflammatory and autoimmune disorders, with an initial focus on immuno-dermatology.

Its proprietary virus-like particle platform is designed to induce targeted immune responses against self-produced proteins that drive disease, offering a potential alternative to conventional biologics with simpler dosing and lower manufacturing costs.

The company's preclinical pipeline includes candidates for senile pruritus, atopic dermatitis, and eczema.